BYDUREON
BYDUREON
Discontinued
DIN Number
02448610
Drug Class
Human
Market Date
Feb 16, 2016
Company
HC
astrazeneca canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02448610
AIG Number0152872002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A10BJ01 EXENATIDE
Product Specifications
Dosage FormKit
,
Powder For Suspension, Sustained-Release
Route of AdministrationSubcutaneous
AHFS Classification68:20.06
Health Canada Classification
ACTIVE INGREDIENTS (1)
EXENATIDEActive
Strength: 2 MG / DOSE
Monograph: EXENATIDE